Brief: HBM Holdings Says Biologics License Application For Batoclimab (Hbm9161) Accepted By NMPA
29/06/2023 11:44
June 29 (Reuters) - HBM Holdings Ltd 2142.HK :
* BIOLOGICS LICENSE APPLICATION FOR BATOCLIMAB (HBM9161)
ACCEPTED
BY NMPA
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study